Dermatology Flashcards
What is eczema? what is the diagnosis?
Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that affects millions of adults worldwide. It is characterized by dry, itchy, and red patches on the skin, which can be exacerbated by environmental triggers such as stress, allergens, and irritants. The condition can significantly impact patients’ quality of life, causing discomfort, sleep disturbance, and psychological distress.
The diagnosis of eczema is based on clinical presentation and history, and management involves a combination of lifestyle modifications, topical treatments, and systemic therapies.
What is the diagnosis of eczema?
UK Working Party Diagnostic Criteria for Atopic Eczema
An itchy skin condition in the last 12 months
Plus three or more of
Onset below age 2 years* History of flexural involvement** History of generally dry skin Personal history of other atopic disease*** Visible flexural dermatitis
not used in children under 4 years
**or dermatitis on the cheeks and/or extensor areas in children aged 18 months or under
**in children aged under 4 years, history of atopic disease in a first degree relative may be included
What are the 8 different management areas to think about in eczema?
Patient Education
Educating patients about their condition and its management is essential for optimal outcomes. This includes information on the chronic nature of eczema, potential triggers, and the importance of adherence to treatment regimens.
Emollients
Emollients are the cornerstone of eczema management and should be used regularly regardless of disease severity. They provide symptomatic relief by hydrating the skin, reducing transepidermal water loss and restoring the skin barrier function. Patients should be advised to apply emollients liberally and frequently (at least twice daily) even when their skin appears clear. Emollient choice should be tailored to individual preferences (e.g., creams, ointments or lotions) to improve adherence.
Topical corticosteroids
Topical corticosteroids are indicated for acute flares and moderate-to-severe eczema. Topical corticosteroids potency should be selected based on disease severity and body site; lower potency topical corticosteroids (e.g., hydrocortisone 1%) can be used on delicate areas such as the face or genitals, whilst higher potency topical corticosteroids (e.g., betamethasone valerate 0.1%) may be required for more severe cases or thicker skin areas like palms or soles.
Topical calcineurin inhibitors
Topical calcineurin inhibitors, such as tacrolimus and pimecrolimus, are an alternative to steroids for eczema management. They are particularly useful in areas where long-term steroids use is contraindicated, such as the face or skin folds. Topical calcineurin inhibitors should be initiated by a specialist dermatologist in cases of severe eczema or when other treatments have failed.
Antimicrobials
In cases of secondary bacterial infection (e.g., impetigo), a short course of topical or oral antibiotics may be necessary. Topical antiseptics can also be used as adjunctive therapy to reduce bacterial colonisation and prevent infection.
Phototherapy
Narrowband ultraviolet B (NB-UVB) phototherapy can be considered for patients with moderate-to-severe eczema who have not responded adequately to topical therapies. This treatment should be supervised by a dermatologist and requires regular monitoring for potential side effects such as erythema, burning, and an increased risk of skin cancer.
Systemic Therapies
Systemic immunosuppressive agents such as ciclosporin, azathioprine or methotrexate may be indicated for severe refractory eczema under the guidance of a specialist dermatologist. These medications require close monitoring due to their potential side effects and interactions with other medications.
Biologic Therapy
Dupilumab, a monoclonal antibody targeting IL-4 and IL-13 pathways, has been approved for use in adults with moderate-to-severe atopic dermatitis unresponsive to conventional therapies. This biologic agent should only be prescribed by specialist dermatologists experienced in managing severe eczema.
How is itch managed?
Management of Itch
Pruritus is a significant symptom associated with eczema that can lead to sleep disturbance and impaired quality of life. The use of sedating antihistamines, such as hydroxyzine or chlorphenamine, can be considered for short-term relief of itch and sleep disturbance. Non-sedating antihistamines (e.g., cetirizine or loratadine) are less effective for itch control but may be useful for managing concomitant allergic symptoms.
List the steroids from mild - very potent
Hydrocortisone
Eumovate (clobetasone butyrate 0.05%)
Cutivate (futicasone proprionate)
Dermovate (Clobetasol propionate 0.05%)
Betnovate (Betamethasone valerate 0.1%)
Betnovate RD (betamethason valerate 0.025%)
Mild Potent Very potent
Hydrocortisone 0.5-2.5%
Moderate
Betamethasone valerate 0.025% (Betnovate RD)
Clobetasone butyrate 0.05% (Eumovate)
Potent
Fluticasone propionate 0.05% (Cutivate)
Betamethasone valerate 0.1% (Betnovate)
Very Potent
Clobetasol propionate 0.05% (Dermovate)
How many fingertip doses per:
Hands and fingers
A foot
Front of chest and abdomen
Bakc and buttocks
Face and neck
An entire arm and hand
An entire leg and foot
Hand and fingers (front and back) 1.0
A foot (all over) 2.0
Front of chest and abdomen 7.0
Back and buttocks 7.0
Face and neck 2.5
An entire arm and hand 4.0
An entire leg and foot 8.0
What amount of steroid should you prescribe for a single daily app for 2 weeks:
Face and neck
Both hands
Scalp
Both arms
Both legs
Trunk
Groin and genitalia
Area Amount
Face and neck 15 to 30 g
Both hands 15 to 30 g
Scalp 15 to 30 g
Both arms 30 to 60 g
Both legs 100 g
Trunk 100 g
Groin and genitalia 15 to 30 g
What is discoid eczema?
Discoid eczema is sometimes referred to as nummular eczema, meaning coin-shaped.
Features
typically present as round or oval plaques on the extremities the lesions are extremely itchy central clearing may occur giving a similar appearance to tinea corporis
What is eczema herpeticum? who is this most commonly seen in?
Eczema herpeticum describes a severe primary infection of the skin by herpes simplex virus 1 or 2.
It is more commonly seen in children with atopic eczema and often presents as a rapidly progressing painful rash.
What is seen on examination of eczema herpeticum? What is the management?
On examination, monomorphic punched-out erosions (circular, depressed, ulcerated lesions) usually 1–3 mm in diameter are typically seen.
As it is potentially life-threatening children should be admitted for IV aciclovir.
What is pompholyx? What may this be precipitated by?
Pompholyx is a type of eczema which affects both the hands (cheiropompholyx) and the feet (pedopompholyx). It is also known as dyshidrotic eczema.
Pompholyx eczema may be precipitated by humidity (e.g. sweating) and high temperatures.
Give 5 features of pompholyx
Features
-small blisters on the palms and soles
-pruritic
-often intensely itchy
-sometimes burning sensation
-once blisters burst skin may become dry and crack
What is the management of pompholyx? 3
Management
-cool compresses
-emollients
-topical steroids
What is psoriasis?
Psoriasis is a common (prevalence around 2%) and chronic skin disorder. It generally presents with red, scaly patches on the skin although it is now recognised that patients with psoriasis are at increased risk of arthritis and cardiovascular disease.
Describe the pathophysiologt of psoriasis
Pathophysiology
multifactorial and not yet fully understood genetic: associated HLA-B13, -B17, and -Cw6. Strong concordance (70%) in identical twins immunological: abnormal T cell activity stimulates keratinocyte proliferation. There is increasing evidence this may be mediated by a novel group of T helper cells producing IL-17, designated Th17. These cells seem to be a third T-effector cell subset in addition to Th1 and Th2 environmental: it is recognised that psoriasis may be worsened (e.g. Skin trauma, stress), triggered (e.g. Streptococcal infection) or improved (e.g. Sunlight) by environmental factors
what are 4 subtypes of psoriasis?
Recognised subtypes of psoriasis
plaque psoriasis: the most common sub-type resulting in the typical well-demarcated red, scaly patches affecting the extensor surfaces, sacrum and scalp
Flexural psoriasis: in contrast to plaque psoriasis the skin is smooth
guttate psoriasis: transient psoriatic rash frequently triggered by a streptococcal infection. Multiple red, teardrop lesions appear on the body
pustular psoriasis: commonly occurs on the palms and soles
What are 5 complications of psoriasis?
Complications
psoriatic arthropathy (around 10%) increased incidence of metabolic syndrome increased incidence of cardiovascular disease increased incidence of venous thromboembolism psychological distress
What are 4 nail changes seen in psoriasis? what percentage of patients are affected?
Psoriatic nail changes affect both fingers and toes and do not reflect the severity of psoriasis but there is an association with psoriatic arthropathy - around 80-90% of patients with psoriatic arthropathy have nail changes.
Nail changes that may be seen in psoriasis
pitting onycholysis (separation of the nail from the nail bed) subungual hyperkeratosis loss of the nail
What are 4 exacerbating features of psoriasis?
The following factors may exacerbate psoriasis:
trauma alcohol drugs: beta blockers, lithium, antimalarials (chloroquine and hydroxychloroquine), NSAIDs and ACE inhibitors, infliximab withdrawal of systemic steroids
Streptococcal infection may trigger guttate psoriasis.
Describe 1st line, 2nd line and 3rd line treatment for psoriasis
NICE recommend a step-wise approach for chronic plaque psoriasis
regular emollients may help to reduce scale loss and reduce pruritus
first-line: NICE recommend:
a potent corticosteroid applied once daily plus vitamin D analogue applied once daily
should be applied separately, one in the morning and the other in the evening)
for up to 4 weeks as initial treatment
second-line: if no improvement after 8 weeks then offer:
a vitamin D analogue twice daily
third-line: if no improvement after 8-12 weeks then offer either:
a potent corticosteroid applied twice daily for up to 4 weeks, or
a coal tar preparation applied once or twice daily
short-acting dithranol can also be used
Secondary care treatment for psoriasis: Phototherapy
-What is the treatment of choice?
-How often should this be given?
-what are 2 adverse effects?
Phototherapy
narrowband ultraviolet B light is now the treatment of choice. If possible this should be given 3 times a week photochemotherapy is also used - psoralen + ultraviolet A light (PUVA) adverse effects: skin ageing, squamous cell cancer (not melanoma)
Secondary care treatment for psoriasis: Systemic therapy
-What is used first line?
-What are 4 other options?
Systemic therapy
oral methotrexate is used first-line. It is particularly useful if there is associated joint disease ciclosporin systemic retinoids biological agents: infliximab, etanercept and adalimumab ustekinumab (IL-12 and IL-23 blocker) is showing promise in early trials
Describe the management of scalp psoriasis
Outline
NICE recommend the use of potent topical corticosteroids used once daily for 4 weeks if no improvement after 4 weeks then either use a different formulation of the potent corticosteroid (for example, a shampoo or mousse) and/or a topical agents to remove adherent scale (for example, agents containing salicylic acid, emollients and oils) before application of the potent corticosteroid
Describe the management of face, flexural and genital psoriasis
Outline
NICE recommend offering a mild or moderate potency corticosteroid applied once or twice daily for a maximum of 2 weeks